Featured
-
-
Article
| Open AccessDevelopment of a self-limiting model of methotrexate-induced mucositis reinforces butyrate as a potential therapy
- A. R. da Silva Ferreira
- , S. A. J. van der Aa
- & J. van Bergenhenegouwen
-
Article
| Open AccessMumio (Shilajit) as a potential chemotherapeutic for the urinary bladder cancer treatment
- T. Kloskowski
- , K. Szeliski
- & M. Pokrywczyńska
-
Article
| Open AccessEvaluation of solid tumor response to sequential treatment cycles via a new computational hybrid approach
- Farshad Moradi Kashkooli
- & M. Soltani
-
Article
| Open AccessSubventricular zone involvement is associated with worse outcome in glioma WHO grade 2 depending on molecular markers
- Philipp Karschnia
- , Jonathan Weller
- & Niklas Thon
-
Article
| Open AccessTreosulfan-induced myalgia in pediatric hematopoietic stem cell transplantation identified by an electronic health record text mining tool
- M. Y. Eileen C. van der Stoep
- , Dagmar Berghuis
- & Juliette Zwaveling
-
Article
| Open AccessRevealing Escherichia coli type II l-asparaginase active site flexible loop in its open, ligand-free conformation
- Maristella Maggi
- , Massimiliano Meli
- & Claudia Scotti
-
Article
| Open AccessAzithromycin concentrations during long-term regimen, a pilot study in patients with MALT lymphoma
- Raphael Scheibenpflug
- , Markus Obermüller
- & Heimo Lagler
-
Article
| Open AccessReinforcement learning derived chemotherapeutic schedules for robust patient-specific therapy
- Brydon Eastman
- , Michelle Przedborski
- & Mohammad Kohandel
-
Article
| Open AccessNovel Prognostic Score for recurrent or metastatic head and neck cancer patients treated with Nivolumab
- Kiyoshi Minohara
- , Takuma Matoba
- & Shinichi Iwasaki
-
Article
| Open AccessCardiac and skeletal muscle predictors of impaired cardiorespiratory fitness post-anthracycline chemotherapy for breast cancer
- Amy A. Kirkham
- , Mark J. Haykowsky
- & Richard B. Thompson
-
Article
| Open AccessComparison of gemcitabine-based chemotherapies for advanced biliary tract cancers by renal function: an exploratory analysis of JCOG1113
- Makoto Ueno
- , Chigusa Morizane
- & Junji Furuse
-
Article
| Open AccessMolecular insight into isoform specific inhibition of PI3K-α and PKC-η with dietary agents through an ensemble pharmacophore and docking studies
- Baki Vijaya Bhaskar
- , Aluru Rammohan
- & Wei Gu
-
Article
| Open AccessAnalysis of chemotherapy-induced peripheral neuropathy using the Japanese Adverse Drug Event Report database
- Misaki Inoue
- , Kiyoka Matsumoto
- & Mitsuhiro Nakamura
-
Article
| Open AccessHeat-activated nanomedicine formulation improves the anticancer potential of the HSP90 inhibitor luminespib in vitro
- Brittany Epp-Ducharme
- , Michael Dunne
- & Christine Allen
-
Article
| Open AccessAcid ceramidase controls apoptosis and increases autophagy in human melanoma cells treated with doxorubicin
- Michele Lai
- , Rachele Amato
- & Mauro Pistello
-
Article
| Open AccessIDH2 mutations in patients with normal karyotype AML predict favorable responses to daunorubicin, cytarabine and cladribine regimen
- Marta Libura
- , Emilia Bialopiotrowicz
- & Olga Haus
-
Article
| Open AccessChemical characterization (LC–MS–ESI), cytotoxic activity and intracellular localization of PAMAM G4 in leukemia cells
- R. Flores-Mejía
- , M. J. Fragoso-Vázquez
- & J. Correa-Basurto
-
Article
| Open AccessA network meta-analysis for neoadjuvant and adjuvant treatments for resectable squamous cell carcinoma of esophagus
- Yunpeng Zhao
- , Yongqiang Wang
- & Xiaogang Zhao
-
Article
| Open AccessSystemic immunity markers associated with lymphocytes predict the survival benefit from paclitaxel plus bevacizumab in HER2 negative advanced breast cancer
- Shogo Nakamoto
- , Masahiko Ikeda
- & Akifumi Notsu
-
Article
| Open AccessInfluence of serum inflammatory cytokines on cytochrome P450 drug metabolising activity during breast cancer chemotherapy: a patient feasibility study
- Rebekah L. I. Crake
- , Matthew R. Strother
- & Margaret J. Currie
-
Article
| Open AccessPhase I dose escalation study of sorafenib plus S-1 for advanced solid tumors
- Hui-Jen Tsai
- , Her-Shyong Shiah
- & Li-Tzong Chen
-
Article
| Open AccessA phase II study of the safety of olanzapine for oxaliplatin based chemotherapy in coloraectal patients
- Junichi Nishimura
- , Akiko Hasegawa
- & Masayuki Ohue
-
Article
| Open AccessPoly(p-phenylenevinylene) nanoparticles modified with antiEGFRvIII for specific glioblastoma therapy
- Yuchao Liang
- , Zelin Li
- & Li-Hua Gao
-
Article
| Open AccessA multiwell plate-based system for toxicity screening under multiple static or cycling oxygen environments
- Ming Yao
- , Glenn Walker
- & Michael P. Gamcsik
-
Article
| Open AccessThe mitotic checkpoint is a targetable vulnerability of carboplatin-resistant triple negative breast cancers
- Stijn Moens
- , Peihua Zhao
- & Frédéric Amant
-
Article
| Open AccessPhase 2 trial of hypoxia activated evofosfamide (TH302) for treatment of recurrent bevacizumab-refractory glioblastoma
- Andrew J. Brenner
- , John Floyd
- & Eudocia Quant Lee
-
Article
| Open AccessElectronic cigarette aerosols alter the expression of cisplatin transporters and increase drug resistance in oral cancer cells
- Jimmy Manyanga
- , Vengatesh Ganapathy
- & Lurdes Queimado
-
Article
| Open AccessA cross-sectional study of ocular surface discomfort and corneal nerve dysfunction after paclitaxel treatment for cancer
- Jeremy Chung Bo Chiang
- , David Goldstein
- & Maria Markoulli
-
Article
| Open AccessFibroblast activation protein targeted near infrared photoimmunotherapy (NIR PIT) overcomes therapeutic resistance in human esophageal cancer
- Ryoichi Katsube
- , Kazuhiro Noma
- & Toshiyoshi Fujiwara
-
Article
| Open AccessEffects of different combined regimens of cisplatin, metformin, and quercetin on nasopharyngeal carcinoma cells and subcutaneous xenografts
- Zhongwei Chen
- , Zhen Zeng
- & Xuan Hong
-
Article
| Open AccessCombination therapy of cisplatin with cilastatin enables an increased dose of cisplatin, enhancing its antitumor effect by suppression of nephrotoxicity
- Masashi Arita
- , Satoshi Watanabe
- & Toshiaki Kikuchi
-
Article
| Open AccessSoluble VCAM-1 promotes gemcitabine resistance via macrophage infiltration and predicts therapeutic response in pancreatic cancer
- Ryota Takahashi
- , Hideaki Ijichi
- & Kazuhiko Koike
-
Article
| Open AccessEribulin as a first-line treatment for soft tissue sarcoma patients with contraindications for doxorubicin
- Kenji Tsuchihashi
- , Hitoshi Kusaba
- & Eishi Baba
-
Article
| Open AccessConcerted cell and in vivo screen for pancreatic ductal adenocarcinoma (PDA) chemotherapeutics
- Somayeh Layeghi-Ghalehsoukhteh
- , Shreoshi Pal Choudhuri
- & Thomas M. Wilkie
-
Article
| Open AccessTowards integration of 64Cu-DOTA-trastuzumab PET-CT and MRI with mathematical modeling to predict response to neoadjuvant therapy in HER2 + breast cancer
- Angela M. Jarrett
- , David A. Hormuth
- & Thomas E. Yankeelov
-
Article
| Open AccessAutologous culture method improves retention of tumors’ native properties
- Yao Tang
- , Qian Xu
- & Jiang Gu
-
Article
| Open AccessA novel patient-derived orthotopic xenograft (PDOX) mouse model of highly-aggressive liver metastasis for identification of candidate effective drug-combinations
- Zhiying Zhang
- , Kaiwen Hu
- & Robert M. Hoffman
-
Article
| Open AccessClinical impact of primary tumour location, early tumour shrinkage, and depth of response in the treatment of metastatic colorectal cancer with first-line chemotherapy plus cetuximab or bevacizumab
- Tamotsu Sagawa
- , Yasushi Sato
- & Tetsuji Takayama
-
Article
| Open AccessPatient-derived ovarian cancer explants: preserved viability and histopathological features in long-term agitation-based cultures
- Sofia Abreu
- , Fernanda Silva
- & Catarina Brito
-
Article
| Open AccessAssociation between neutropenia and survival to nab-paclitaxel and gemcitabine in patients with metastatic pancreatic cancer
- Giandomenico Roviello
- , Monica Ramello
- & Enrico Mini
-
Article
| Open AccessBioanalysis of doxorubicin aglycone metabolites in human plasma samples–implications for doxorubicin drug monitoring
- Christian Siebel
- , Claudia Lanvers-Kaminsky
- & Joachim Boos
-
Article
| Open Access3D echocardiography, arterial stiffness, and biomarkers in early diagnosis and prediction of CHOP-induced cardiotoxicity in non-Hodgkin’s lymphoma
- Diana Mihalcea
- , Maria Florescu
- & Dragos Vinereanu
-
Article
| Open AccessSalinomycin induces autophagic cell death in salinomycin-sensitive melanoma cells through inhibition of autophagic flux
- Yajing Liu
- , Yinghua Hao
- & Zhengyu Fang
-
Article
| Open AccessAdjuvant chemotherapy after radical nephroureterectomy improves the survival outcome of high-risk upper tract urothelial carcinoma patients with cardiovascular comorbidity
- Yong Luo
- , Bingfu Feng
- & Yongguang Jiang
-
Article
| Open AccessToll-like receptor 4 (TLR4) expression is correlated with T2* iron deposition in response to doxorubicin treatment: cardiotoxicity risk assessment
- Nelu-Mihai Trofenciuc
- , Aurora Diana Bordejevic
- & Adina Ligia Pop-Moldovan
-
Article
| Open AccessPreliminary insights into the impact of primary radiochemotherapy on the salivary microbiome in head and neck squamous cell carcinoma
- Christina Kumpitsch
- , Christine Moissl-Eichinger
- & Axel Wolf
-
Article
| Open AccessCytotoxic activity of bromodomain inhibitor NVS-CECR2-1 on human cancer cells
- Seul Gi Park
- , Daye Lee
- & Jongbum Kwon
-
Article
| Open AccessSodium nitrate co-supplementation does not exacerbate low dose metronomic doxorubicin-induced cachexia in healthy mice
- Dean G. Campelj
- , Danielle A. Debruin
- & Emma Rybalka
-
Article
| Open AccessDepletion of senescent-like neuronal cells alleviates cisplatin-induced peripheral neuropathy in mice
- Scarlett Acklin
- , Manchao Zhang
- & Fen Xia